The legal issue in question here is whether the Trump Administration’s funding pause is an “impoundment” in violation of the separation of powers clauses in the Constitution and under the Impoundment ...

Visteon Corporation (NASDAQ: VC) today reported fourth quarter and full-year 2024 financial results. Highlights include: ...

Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) submissions for lenacapavir—the company’s twice-yearly ...

Light AI Inc. ("Light AI" or the "Company") (CBOE CA: ALGO) , a global healthcare technology company focused on developing artificial intelligence health diagnostic and wellness solutions today is ...

President Donald Trump has had one of the most active first months in office of any U.S. president. Since Trump’s inauguration, Connecticut Attorney General William Tong has been active in challenging ...

Policy makers should continue to provide clear rules of the road, increase transparency, apply more effective oversight, and ...

for a decision on marketing authorization for TNX-102 SL (cyclobenzaprine HCl sublingual tablets) 5.6 mg for the management of fibromyalgia.

Northisle is pleased to announce the results of the updated Preliminary Economic Assessment on the North Island Project.

As of February 17, 2025, 1,028 unique patient prescriptions for Attruby™ have been written by 516 unique prescribers since FDA approval- ...

QUAD’s current management team will continue running the combined company after the Transaction.